news-and-events – Heranova

news + events

Heranova Lifesciences to Spotlight Diagnostic Innovation in Endometriosis at Global Women’s Health Conferences This June

Heranova Lifesciences Presents New Data on Endometriosis Detection Blood Test at SEUD Congress 2025

Heranova Lifesciences Selected for presentations at 6 Conferences to date in 2025

Heranova Launches LDT-Validated HerResolve™ in the U.S., Advancing Non-Invasive Endometriosis Diagnosis for Women

Heranova Lifesciences Announces 2025 Conference Schedule

Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian Conference in Hong Kong

Heranova™ Launches Early Access Program for HerResolve™, a Potential First FDA-Cleared, Non-Invasive Endometriosis Test

Heranova™ Appoints Dr. Marcel van Duin as Chief Scientific Officer

Heranova™ Lifesciences Debuts with $13.5 Million Seed and Seed+ Round Funding to Offer Integrated Clinical Solutions to Women’s Health